Internal Medicine, Hematology & Oncology · Princeton, NJ
NPI
1770621575
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
419 N Harrison St
Princeton, NJ, 08540
Phone (609) 924-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
92,888 services
Medicare patients, 2024
471
Average age 77
Drug cost, 2024
$2.3M
1,443 prescriptions
Company payments, 2025
$342
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard T Lee was code J1439 (injection, ferric carboxymaltose, 1 mg), 17,250 times for 14 patients. In total Richard T Lee billed 92,888 services in 105 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 17,250 | 14 | $0.88 | $15K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,500 | 14 | $0.11 | $825 |
| J0897 Injection, denosumab, 1 mg | Office | 4,620 | 11 | $20.66 | $95K |
| 36415 Venipuncture Blood Collection | Office | 1,087 | 367 | $8.64 | $9,396 |
| 85025 Blood Count | Office | 1,069 | 364 | $7.61 | $8,130 |
| 80053 Clinical Chemistry | Office | 868 | 322 | $10.33 | $8,967 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 824 | 20 | $0.09 | $72.33 |
| 99214 Office E&M - Established | Office | 679 | 239 | $103.51 | $70K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 650 | 18 | $0.69 | $451 |
| 99213 Office E&M - Established | Office | 502 | 267 | $70.99 | $36K |
| 96375 Injection Administration | Office | 351 | 28 | $13.55 | $4,756 |
| 82728 Clinical Chemistry | Office | 234 | 123 | $13.36 | $3,126 |
| 96413 Chemotherapy Administration | Office | 186 | 34 | $115.33 | $21K |
| 96372 Injection Administration | Office | 169 | 33 | $11.72 | $1,980 |
| 83615 Clinical Chemistry | Office | 139 | 71 | $5.92 | $823 |
By year: 2022 $1.6M for 122,970 services; 2023 $1.5M for 93,703 services; 2024 $1.2M for 92,888 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,087 | 367 | $8.64 | $9,396 |
| 85025 Blood Count | 1,069 | 364 | $7.61 | $8,130 |
| 80053 Clinical Chemistry | 868 | 322 | $10.33 | $8,967 |
| 82728 Clinical Chemistry | 234 | 123 | $13.36 | $3,126 |
| 83615 Clinical Chemistry | 139 | 71 | $5.92 | $823 |
| 82607 Clinical Chemistry | 63 | 50 | $14.78 | $931 |
| 82378 Clinical Chemistry | 60 | 32 | $18.39 | $1,104 |
| 84443 Clinical Chemistry | 37 | 22 | $16.46 | $609 |
| 85651 Clinical Chemistry | 13 | 11 | $4.18 | $54.34 |
Medicare prescription drug claims, 2024
In 2024, the drug Richard T Lee prescribed most often to Medicare patients was Anastrozole, with 512 prescriptions and refills. In total Richard T Lee wrote 1,443 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 512 | 1,490 | 157 | $14K |
| Tamoxifen Citrate Generic | 63 | 163 | 18 | $1,965 |
| Letrozole Generic | 60 | 158 | 16 | $1,279 |
| Exemestane Generic | 54 | 148 | 18 | $8,203 |
| Hydroxyurea Generic | 44 | 118 | 12 | $1,272 |
| Ondansetron Hcl Generic | 36 | 38 | 26 | $179 |
| Eliquis Apixaban | 33 | 55 | Under 11 | $31K |
| Aranesp Darbepoetin Alfa In Polysorbat | 28 | 28 | Under 11 | $78K |
| Prochlorperazine Maleate Generic | 26 | 26 | 22 | $238 |
| Verzenio Abemaciclib | 26 | 26 | Under 11 | $397K |
| Xarelto Rivaroxaban | 24 | 50 | Under 11 | $27K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 24 | 24 | Under 11 | $266 |
| Dexamethasone Generic | 23 | 27 | 19 | $574 |
| Neulasta Onpro Pegfilgrastim | 19 | 19 | Under 11 | $119K |
| Kisqali Ribociclib Succinate | 19 | 19 | Under 11 | $242K |
Brand drugs: 306 claims; generic drugs: 1,137 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard T Lee $342 ($342 in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $140.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.